Evidence map›Paper›PMID 39934698›Full record

ArticleBMC cardiovascular disorders2025

The new definition of metabolic syndrome including hyperuricemia improves its prognostic value: results from NHANES database.

Zhichao Zhang, Yuanxin Pang, Jun Shen, Weihai Chen, ChuanZhen Hao, Zhijun Lei

Abstract read
In one paragraph

Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhichao Zhang *Department of Electrocardiogram Room, Suzhou Ninth People's Hospital, Suzhou Ninth Hospital, Soochow University, Suzhou, China.
Yuanxin Pang *Department of Endocrinology, Suzhou Ninth People's Hospital, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China.
Jun ShenDepartment of Cardiology, Suzhou Ninth People's Hospital, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China.
Weihai ChenDepartment of Cardiology, Suzhou Ninth People's Hospital, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China.
ChuanZhen HaoDepartment of Geriatrics, Jiangwan Hospital, Shanghai, China. hcz18669305350@163.com.
Zhijun LeiDepartment of Cardiology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China. tc_leizj@163.com.

Funding

The Project of Suzhou Science and Technology Bureau SYSD2019202The project of the Suzhou Ninth People's Hospital YK202210
6 · The paper itself

Abstract

backgroundMetabolic syndrome (MetS) is a significant global health issue that is strongly associated with an increased risk of cardiovascular disease (CVD). While MetS was initially proposed to identify more high-risk individuals and facilitate early management, hyperuricemia has not yet been included in its definition, despite its strong association with MetS. This study aims to explore the prognostic value of incorporating hyperuricemia into the definition of MetS.

methodsData derived from the National Health and Nutrition Examination Survey (NHANES) conducted between 1999 and 2018 were analyzed. The old version of MetS (MetS

resultsAmong the 36,363 participants analyzed, 12,594 (34.6%) and 14,137 (38.9%) met MetS

conclusionsThe inclusion of hyperuricemia in the MetS criteria could identify a larger proportion of individuals at metabolic risk, thereby facilitating early management to prevent long-term adverse events.

Indexed as

Cardiovascular DiseasesHyperuricemiaMetabolic SyndromeTerminology as TopicUric AcidAdultAgedBiomarkersCross-Sectional StudiesDatabases, FactualFemaleHumansMaleMiddle AgedNutrition SurveysPredictive Value of TestsBiomarkersUric AcidHyperuricemiaMetabolic syndromeMortalityPrognostic value

Identifiers

PMID39934698
PMCPMC11817069

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.